Pharmacologic and clinical properties of indisetron hydrochloride, a new 5-HT3 receptor antagonist for treating nausea and vomiting during cancer treatment

Japanese Pharmacology and Therapeutics

Volumn 33, Issue 1, 2005, Pages 17-45

  Fujiwara, T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; CISPLATIN; CYTOCHROME P450 1A1; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; INDISETRON; SEROTONIN 3 ANTAGONIST; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR;

AREA UNDER THE CURVE; CANCER CHEMOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL TRIAL; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG METABOLISM; DRUG RECEPTOR BINDING; ENZYME INHIBITION; HUMAN; NAUSEA; REVIEW;

EID: 21044444779     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. 4 receptors. Res Commun Mol Pathol Pharmacol 2001; 109: 217-30.
2. 1A receptors on isolated rat abdominal vague nerve. Jpn J Pharmacol 2001; 85 suppl 1: 113.
3. 4 receptor antagonist, in ferrets. Eur J Pharmacol 1997; 321: 333-42.
4. 3 receptors, in the emesis sunduced by high-dose cisplatin in Suncus murinus. Jpn J Pharmacol 2001; 85: 70-4.